CorMedix (CRMD) Deferred Taxes (2010 - 2025)

CorMedix (CRMD) reported Deferred Taxes of $33.9 million for Q4 2025, up 156.77% sequentially from -$59.7 million in Q3 2025.

CorMedix (CRMD) Deferred Taxes (2010 - 2025) Analysis & Trends

CorMedix (CRMD) has 7 years of Deferred Taxes data on file, last reported at $33.9 million in Q4 2025.

For the quarter ending Q4 2025, Deferred Taxes changed N/A year-over-year to $33.9 million; the trailing twelve-month figure through Dec 2025 stood at -$25.8 million (changed N/A YoY), and the FY2025 full-year result was -$25.8 million, changed N/A from the prior year.
Deferred Taxes improved to $33.9 million in Q4 2025, from -$59.7 million in the prior quarter.
In the past five years, Deferred Taxes ranged from a high of $33.9 million in Q4 2025 to a low of -$59.7 million in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Deferred Taxes (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-188,883.60
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-65.30 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	96.00 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	CorMedix	546.82 Mn	391.62 Mn	107.31 Mn	33.89 Mn

Download Data